HONEYLYNN ABAYA: Open Payments
NPI 1528799145 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 21 payments from 8 companies in 2025. Trend: 2023 $607 · 2024 $581 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $254 |
| Ardelyx, Inc. | 8 | $237 |
| Fresenius USA Marketing, Inc. | 2 | $51 |
| Novo Nordisk Inc | 1 | $24 |
| AKEBIA THERAPEUTICS INC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Recor Medical Inc | 1 | $19 |
| Medtronic, Inc. | 1 | $14 |
Products named: IBSRELA, LOKELMA, FARXIGA, VELPHORO, Ozempic, Vafseo, Kerendia, Paradise Ultrasound Renal Denervation System.
Industry payments across CA — which companies pay providers there.
